Radioligand Therapy (RLT) Market Analysis: Industry Developments, Regional Insights, and Future Opportunities
The Radioligand Therapy (RLT) Market is positioned for substantial long-term expansion as personalized cancer treatment becomes increasingly important. The global market was valued at USD 8.14 billion in 2024 and is projected to grow from USD 8.906 billion in 2025 to USD 21.89 billion by 2035, registering a CAGR of 9.41% during 2025–2035. North America led the market in 2024 with...
0 Comments 0 Shares 134 Views 0 Reviews